We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current NVAX market cap is 550.02M. The company's latest EPS is USD -3.8946 and P/E is -1.00.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 734.58M | 357.4M | 80.95M | 424.43M | 186.99M |
| Operating Income | -127.19M | -243.88M | -312.77M | 55.46M | -125.63M |
| Net Income | -168.61M | -182.25M | -293.91M | 58.01M | -130.78M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 18.66M | 475.6M | 1.15B | 1.98B | 983.71M |
| Operating Income | -129.6M | -416.72M | -1.69B | -644.74M | -566.51M |
| Net Income | -132.69M | -418.26M | -1.74B | -657.94M | -545.06M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 2.27B | 2.26B | 1.54B | 1.69B | 1.66B |
| Total Liabilities | 2.83B | 2.89B | 2.44B | 2.44B | 2.34B |
| Total Equity | -565.99M | -634.08M | -895.58M | -754.52M | -678.35M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 172.96M | 1.58B | 2.58B | 2.26B | 1.8B |
| Total Liabilities | 358.97M | 955.27M | 2.93B | 2.89B | 2.51B |
| Total Equity | -186.02M | 627.21M | -351.67M | -634.08M | -716.93M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -298.12M | -415.94M | -325.59M | -497.53M | -537.19M |
| Investing | -70.92M | -92.99M | -23.56M | -31.34M | -49.73M |
| Financing | 133.55M | 324.99M | -354.38M | -293.04M | -95.92M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -136.62M | -42.54M | 322.95M | -415.94M | -713.97M |
| Investing | 38.49M | -377.78M | 100.15M | -92.99M | -58.81M |
| Financing | 98.38M | 984.76M | 461.71M | 324.99M | 4.47M |
| Market Cap | 550.02M |
| Price to Earnings Ratio | -1.00 |
| Price to Sales Ratio | 0.55 |
| Price to Cash Ratio | 0.96 |
| Price to Book Ratio | -0.76 |
| Dividend Yield | - |
| Shares Outstanding | 139.95M |
| Average Volume (1 week) | 3.89M |
| Average Volume (1 Month) | 3.84M |
| 52 Week Change | -58.81% |
| 52 Week High | 11.36 |
| 52 Week Low | 3.5324 |
| Spread (Intraday) | 0.05 (1.27%) |
| Company Name | Novavax Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.novavax.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
